Sangamo Therapeutics Inc. (SGMO): This Small-Cap Stock Is Poised To Outperform in 2025

Yahoo FinanceJan 8 00:32

Pharma Stock Roundup: PFE Ends Hemophilia Deal With SGMO & More

Zacks Jan 3 21:05

Jefferies Maintains Sangamo Therapeutics(SGMO.US) With Buy Rating, Maintains Target Price $3

Futu NewsJan 2 23:32 · Ratings

HC Wainwright & Co. Reiterates Buy on Sangamo Therapeutics, Maintains $10 Price Target

BenzingaJan 2 22:21 · Ratings

Wells Fargo Maintains Sangamo Therapeutics(SGMO.US) With Hold Rating, Cuts Target Price to $2

Futu NewsJan 2 20:32 · Ratings

Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership -- Barrons.com

Barron'sJan 2 20:03